Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for AstraZeneca
Company Monitoring Page for AstraZeneca
latest headlines for company on cafepharma
Being Second In Line No Hurdle In Pharma
Yahoo/Investors Business Daily
Fri, 04/10/09 - 08:29 am
Tags:
diabetes
,
Bristol-Myers Squibb
,
AstraZeneca
,
Onglyza
,
Merck
,
Januvia
Bristol an Attractive Value
Yahoo/Zacks.com
Thu, 04/9/09 - 10:15 am
Tags:
Bristol-Myers Squibb
,
Otsuka
,
Exelixis
,
ZymoGenetics
,
Sanofi
,
AstraZeneca
FDA Panel: Seroquel not 1st choice for depression
Yahoo/AP
Wed, 04/8/09 - 07:37 pm
Tags:
FDA
,
depression
,
AstraZeneca
,
Seroquel
Pharma CEOs Strike Collaborative Tone On Health Reform
The RPM Report
Wed, 04/8/09 - 11:13 am
Tags:
Pharma CEOs
,
AstraZeneca
,
Merck
,
healthcare reform
FDA panel to consider weight gain and heart risk versus benefits of Seroquel for depression
Yahoo/AP
Wed, 04/8/09 - 08:30 am
Tags:
FDA
,
Seroquel
,
AstraZeneca
,
depression
,
schizophrenia
FDA Calendar Updates: Santarus, Cephalon, AstraZeneca, Dendreon, Gilead, Novo Nordisk
Seeking Alpha
Tue, 04/7/09 - 09:22 am
Tags:
FDA
,
Santarus
,
Cephalon
,
AstraZeneca
,
Dendreon
,
Gilead Sciences
,
Novo Nordisk
AstraZeneca files lawsuit against Apotex
Marketwatch
Tue, 04/7/09 - 08:31 am
Tags:
AstraZeneca
,
Apotex
,
Pulmicort
,
patents
FDA asks for more data on AstraZeneca's Symbicort
Yahoo/AP
Mon, 04/6/09 - 08:35 am
Tags:
FDA
,
AstraZeneca
,
Symbicort
,
asthma
Bristol-Myers climbs in pre-market trade on FDA nod
Marketwatch
Thu, 04/2/09 - 09:35 am
Tags:
FDA
,
Bristol-Myers Squibb
,
diabetes
,
Onglyza
,
AstraZeneca
FDA and Clinical Trial Updates: Weight Loss, Diabetes and More
Seeking Alpha
Thu, 04/2/09 - 07:26 am
Tags:
Acorda Therapeutics
,
Arena Pharmaceuticals
,
AstraZeneca
,
Bristol-Myers Squibb
,
Genentech
,
GSK
,
Pfizer
,
Sepracor
,
Roche
,
Wyeth
,
Orthovita
Which Diabetes Drugs Will Win Out?
Seeking Alpha
Thu, 04/2/09 - 06:12 am
Tags:
diabetes
,
Alkermes
,
Eli Lilly
,
Amylin
,
AstraZeneca
,
Bristol-Myers Squibb
,
GSK
,
Takeda
,
Merck
,
Novo Nordisk
Amylin, Novo Nordisk buck downward trend
Marketwatch
Wed, 04/1/09 - 03:50 pm
Tags:
Amylin
,
Novo Nordisk
,
Celgene
,
Eli Lilly
,
Alkermes
,
AstraZeneca
FDA meeting on Bristol-Myers Squibb diabetes drug has implications for industry
Yahoo/AP
Wed, 04/1/09 - 07:16 am
Tags:
FDA
,
diabetes
,
Bristol-Myers Squibb
,
Onglyza
,
GSK
,
AstraZeneca
Pharma's Big Drug Test
CNBC
Wed, 04/1/09 - 06:15 am
Tags:
Merck
,
GSK
,
Alkermes
,
Eli Lilly
,
Amylin
,
AstraZeneca
,
Bristol-Myers Squibb
Pharma's Refreshing Bad News
Motley Fool
Tue, 03/31/09 - 04:48 pm
Tags:
drug trials
,
Schering Plough
,
AstraZeneca
,
Eli Lilly
,
JNJ
,
Pfizer
The Best Pipeline In Biotech
Yahoo/Zacks.com
Tue, 03/31/09 - 09:05 am
Tags:
biotech
,
pipelines
,
Biogen Idec
,
AstraZeneca
,
Bristol-Myers Squibb
Statins: Looking Beyond Their Effects on LDL Cholesterol
WSJ Online
Tue, 03/31/09 - 09:01 am
Tags:
cholesterol
,
statins
,
Crestor
,
AstraZeneca
Avastin-Like Drug Reduces Brain Swelling, Not Tumors, in Study
Bloomberg
Mon, 03/30/09 - 05:06 pm
Tags:
Avastin
,
Roche
,
AstraZeneca
Abbott Labs Cures What Ails
Yahoo/Zacks.com
Mon, 03/30/09 - 05:03 pm
Tags:
Abbott Laboratories
,
AstraZeneca
To the Moon, Crestor?
Motley Fool
Mon, 03/30/09 - 05:01 pm
Tags:
Crestor
,
AstraZeneca
,
JUPITER
Pages
« first
‹ previous
…
160
161
162
163
164
165
166
167
168
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.